Notifications
Clear all
Pirate's Cove
1
Posts
1
Users
0
Reactions
138
Views
May. 13, 2020 10:16 pm
On May 11 NYU Grossman School of Medicine
released the results of a study involving 932 CV infected people.
The results:
NEW YORK - Researchers at NYU's Grossman School of Medicine found patients given the antimalarial drug hydroxychloroquine along with zinc sulphate and the antibiotic azithromycin were 44 percent less likely to die from the coronavirus.
"Certainly we have very limited options as far as what we have seen work for this infection so anything that may work is very exciting," said Dr. Joseph Rahimian, Infectious Disease Specialist at NYU Langone Health.
